当前位置: X-MOL 学术Diabetes Technol. Ther. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
What's Wrong with This Picture? A Critical Review of Current Centers for Medicare & Medicaid Services Coverage Criteria for Continuous Glucose Monitoring
Diabetes Technology & Therapeutics ( IF 5.4 ) Pub Date : 2021-09-01 , DOI: 10.1089/dia.2021.0107
Rodolfo J Galindo 1, 2, 3 , Christopher G Parkin 4 , Grazia Aleppo 5 , Anders L Carlson 6, 7, 8, 9 , Davida F Kruger 10 , Carol J Levy 11, 12 , Guillermo E Umpierrez 13, 14 , Janet B McGill 15
Affiliation  

Numerous studies have demonstrated the clinical value of continuous glucose monitoring (CGM) in type 1 diabetes and type 2 diabetes populations. However, the eligibility criteria for CGM coverage required by the Centers for Medicare & Medicaid Services (CMS) ignore conclusive evidence that supports CGM use in various diabetes populations that are currently deemed ineligible. This article discusses the limitations and inconsistencies of the CMS eligibility criteria relative to current scientific evidence and proposes workable solutions to address this issue and improve the safety and care of all individuals with diabetes.

中文翻译:

这张图片有什么问题?对当前医疗保险和医疗补助服务中心持续血糖监测的覆盖标准进行严格审查

大量研究证明了持续血糖监测 (CGM) 在 1 型糖尿病和 2 型糖尿病人群中的临床价值。然而,医疗保险和医疗补助服务中心 (CMS) 要求的 CGM 覆盖范围的资格标准忽略了支持 CGM 在目前被认为不合格的各种糖尿病人群中使用的确凿证据。本文讨论了 CMS 资格标准相对于当前科学证据的局限性和不一致之处,并提出了可行的解决方案来解决这个问题并改善所有糖尿病患者的安全和护理。
更新日期:2021-09-03
down
wechat
bug